Search
Now showing items 1-1 of 1
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
(Massachusetts Medical Society, 2010-09-30)
Background The survival rate among patients with intermediate-risk neuroblastoma who receivedose-intensive chemotherapy is excellent, but the survival rate among patients whoreceive reduced doses of chemotherapy for shorter ...